Press release
Leading Growth Driver in the Advanced Therapeutics Pharmaceutical Outsourcing Market in 2025: Impact Of Cell and Gene Therapies On The Advanced Therapeutics Pharmaceutical Outsourcing Market Driver's Influence
Advanced Therapeutics Pharmaceutical Outsourcing Market
The growth of the advanced therapeutics pharmaceutical outsourcing market is predicted to be fueled by the escalating usage of cell and gene therapies. These transformative treatments rely on live cells or genetic material to remedy or entirely eliminate diseases. Outsourcing in advanced therapeutics pharmaceuticals is employed in cell and gene therapies to allow for partnering with established and expert providers, thus relieving companies from the burden of team building and resource allocation. According to a November 2023 citation from Nature, a UK-based science periodical, there will be a jump in the number of new patients treated with gene therapies, from 16,244 in 2020 to 94,696 in 2025. Consequently, the burgeoning utilization of cell and gene therapies is bolstering the expansion of the advanced therapeutics pharmaceutical outsourcing market.
Get Your Advanced Therapeutics Pharmaceutical Outsourcing Market Report Here:
https://www.thebusinessresearchcompany.com/report/advanced-therapeutics-pharmaceutical-outsourcing-global-market-report
What is the future CAGR of the advanced therapeutics pharmaceutical outsourcing market, and how will it impact industry expansion?
The size of the advanced therapeutics pharmaceutical outsourcing market has been experiencing consistent growth in the past few years. The market is projected to expand from $8.07 billion in 2024 to $8.43 billion in 2025, showing a Compound Annual Growth Rate (CAGR) of 4.5%. Factors driving growth during the historic period include enhanced biopharmaceutical infrastructure, regulatory adherence, rising demand for innovative medications to address chronic and severe illnesses, improved effectiveness, and an escalation in the demand for custom-made medicine.
Expectations are that the advanced therapeutics pharmaceutical outsourcing market will experience significant expansion in the coming years. With a compound annual growth rate (CAGR) of 5.1%, the market value is set to reach $10.27 billion by 2029. This forecasted growth can be credited to the increased implementation of cell and gene therapies, a growing concentration on mRNA therapies, enhanced demand for advanced treatments, the efficiency and cost-effectiveness provided by outsourcing, and cooperative innovation. Notable trends for the forecast period include technological progression, increased specialization in advanced therapeutics, a growing influx of new, innovative therapies, heightened integration of cutting-edge technology, and considerable progress in gene therapy, cell therapy, and mRNA technologies.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13768&type=smp
What are the most significant trends transforming the advanced therapeutics pharmaceutical outsourcing market today?
Prominent firms in the advanced therapeutics pharmaceutical outsourcing market are prioritising strategic alliances to deliver trustworthy services to their clients. A strategic partnership is a cooperative agreement between two or more entities, typically firms, designed to accomplish joint benefits that cannot be independently achieved. For instance, in January 2023, Lonza, a manufacturing company for the pharmaceutical, biotech and nutrition industries based in Switzerland, formed a partnership with Context Therapeutics Inc., a U.S. biopharmaceutical firm that develops medicines for solid tumors. The collaboration entails Lonza offering services like manufacturability assessment, gene and cell line construction, and the development of processes for drug substances and drug products.
Which key market segments comprise the advanced therapeutics pharmaceutical outsourcing market and drive its revenue growth?
The advanced therapeutics pharmaceutical outsourcing market covered in this report is segmented -
1) By Service Type: Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)
2) By Indication: Oncology, Neurology, Cardiology, Infectious Diseases, Other Indications
3) By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies
4) By Application: Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging
Subsegments:
1) By Contract Research Organizations (CROs): Preclinical Research Services, Clinical Trial Management Services, Regulatory Affairs Services, Data Management And Biostatistics
2) By Contract Development And Manufacturing Organizations (CDMOs): Drug Development Services, Formulation Development, Analytical Testing Services, Commercial Manufacturing Services
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13768
What regions are at the forefront of advanced therapeutics pharmaceutical outsourcing market expansion?
North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2024. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the leading players fueling growth in the advanced therapeutics pharmaceutical outsourcing market?
Major companies operating in the advanced therapeutics pharmaceutical outsourcing market report are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Croda International Plc, Samsung Biologics, Vetter Pharma International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies, Marken, AGC Biologics, Evotec SE, ProPharma Group, Piramal Pharma Solutions, Corden Pharma International LLC, Novotech Pty Ltd., Cryoport Systems Inc., Cytovance Biologics
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13768&type=smp
What Is Covered In The Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report?
• Market Size Forecast: Examine the advanced therapeutics pharmaceutical outsourcing market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the advanced therapeutics pharmaceutical outsourcing market for a structured understanding.
• Key Players Overview: Analyze major players in the advanced therapeutics pharmaceutical outsourcing market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the advanced therapeutics pharmaceutical outsourcing market.
• Segment Contributions: Evaluate how different segments drive overall growth in the advanced therapeutics pharmaceutical outsourcing market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the advanced therapeutics pharmaceutical outsourcing market.
• Industry Challenges: Identify potential risks and obstacles affecting the advanced therapeutics pharmaceutical outsourcing market.
• Competitive Landscape: Review strategic developments in the advanced therapeutics pharmaceutical outsourcing market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Growth Driver in the Advanced Therapeutics Pharmaceutical Outsourcing Market in 2025: Impact Of Cell and Gene Therapies On The Advanced Therapeutics Pharmaceutical Outsourcing Market Driver's Influence here
News-ID: 3903338 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
